Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
PLA2R1	0	broad.mit.edu	37	2	160798656	160798656	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr2:160798656C>T	ENST00000283243.7	-	29	4365	c.4159G>A	c.(4159-4161)Gag>Aag	p.E1387K	PLA2R1_ENST00000460710.1_5'UTR	NM_001195641.1|NM_007366.4	NP_001182570.1|NP_031392.3	Q13018	PLA2R_HUMAN	phospholipase A2 receptor 1, 180kDa	1387		NA		NA	endocytosis	extracellular space|integral to plasma membrane	receptor activity|sugar binding		PLA2R1/RBMS1(2)	central_nervous_system(1)|endometrium(8)|kidney(2)|large_intestine(17)|lung(20)|ovary(1)|pancreas(1)|prostate(1)|skin(7)|stomach(1)|upper_aerodigestive_tract(1)	60						GGCAGCGCCTCTGCAGTGTGA	0.299		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						48	53	51	NA		NA	NA	2		NA		NA									NA				160798656		2202	4300	6502	SO:0001583	missense			ENSG00000153246	HGNC:9042		Approved	uc002ube.2	NA	B2RTU9|D3DPB1|Q13019|Q15095|Q53R45|Q53RR7	ENST00000283243.7	37	CCDS33309.1	.	.	.	.	.	.	.	.	.	.	C	0.019	-1.463623	0.01062	.	.	ENSG00000153246	ENST00000283243	T	0.06218	3.33	5.89	3.49	0.39957	.	0.857935	0.10467	N	0.671256	T	0.03095	0.0091	N	0.08118	0	0.09310	N	0.999992	B;B	0.02656	0.0;0.0	B;B	0.01281	0.0;0.0	T	0.46569	-0.9182	10	0.07030	T	0.85	.	7.3477	0.26672	0.0:0.0755:0.1562:0.7682	.	1385;1387	B7ZML4;Q13018	.;PLA2R_HUMAN	K	1387	ENSP00000283243:E1387K	ENSP00000283243:E1387K	E	-	1	0	PLA2R1	160506902	0.002000	0.14202	0.001000	0.08648	0.003000	0.03518	0.557000	0.23454	0.455000	0.26910	-0.302000	0.09304	GAG	PLA2R1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000333820.1	8.267104	KEEP	NA	-	19.968168	0.097222	7	65	---	---	---	---	0	0.6631753	0	20	0	53	9	75	0	53	2	1	1	85	984	0	988	9	75	0	53	2	TP
LRIG1	26018	broad.mit.edu	37	3	66434551	66434551	+	Silent	SNP	C	C	T			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr3:66434551C>T	ENST00000273261.3	-	14	2459	c.1935G>A	c.(1933-1935)gaG>gaA	p.E645E	SLC25A26_ENST00000536651.1_Intron|LRIG1_ENST00000496559.2_5'UTR|LRIG1_ENST00000383703.3_Intron	NM_015541.2	NP_056356.2	Q96JA1	LRIG1_HUMAN	leucine-rich repeats and immunoglobulin-like domains 1	645	Ig-like C2-type 2.	NA		NA		integral to membrane				NS(2)|breast(2)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(7)|lung(12)|ovary(3)|prostate(1)|skin(4)|stomach(4)|urinary_tract(1)	42		Lung NSC(201;0.0101)		BRCA - Breast invasive adenocarcinoma(55;0.00047)		GCATGCGTCGCTCACGGGCAG	0.567		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						130	117	122	NA		NA	NA	3		NA		NA									NA				66434551		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000144749	HGNC:17360	NM_015541	Approved	uc003dmx.3	NA	Q6IQ51|Q96CF9|Q9BYB8|Q9UFI4	ENST00000273261.3	37	CCDS33783.1																																																																																			LRIG1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000351930.1	-13.494768	KEEP	NA	-	24.592279	0.058824	11	176	---	---	---	---	1	0.7460802	3	40	0	133	12	187	0	133	2	0	0	0	0	0	0	12	187	0	133	2	TP
HPS3	84343	broad.mit.edu	37	3	148889914	148889914	+	Silent	SNP	C	C	T			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr3:148889914C>T	ENST00000296051.2	+	17	3060	c.2920C>T	c.(2920-2922)Ctg>Ttg	p.L974L	HPS3_ENST00000460120.1_Silent_p.L809L	NM_032383.3	NP_115759.2	Q969F9	HPS3_HUMAN	Hermansky-Pudlak syndrome 3	974		NA		NA		cytoplasm				breast(2)|endometrium(2)|kidney(1)|large_intestine(7)|lung(12)|ovary(5)|prostate(1)|skin(1)|upper_aerodigestive_tract(3)	34			LUSC - Lung squamous cell carcinoma(72;0.0473)|Lung(72;0.0607)			GGAACTAGAACTGAAGGATTT	0.343		NA				NA		NA	Hermansky-Pudlak syndrome		NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						113	109	110	NA		NA	NA	3		NA		NA									NA				148889914		2202	4300	6502	SO:0001819	synonymous_variant	Familial Cancer Database	HPS, HPS1-8	ENSG00000163755	HGNC:15597	NM_032383	Approved	uc003ewu.1	NA	A8K6G6|Q8WTV6|Q96AP1|Q96MR3|Q9H608	ENST00000296051.2	37	CCDS3140.1																																																																																			HPS3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000356151.1	60.069721	KEEP	NA	+	63.11023	0.28169	20	51	---	---	---	---	1	1	57	84	0	75	20	55	0	75	2	0	0	0	0	0	0	20	55	0	75	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome		NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA						112	104	107	NA		NA	NA	7		NA		NA									NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	106.826183	KEEP	NA	-	109.712844	0.32381	34	71	---	---	---	---	1	0.978996	8	9	0	111	36	81	0	111	2	1	1	515	998	7	1415	36	81	0	111	16	TP
NSMAF	8439	broad.mit.edu	37	8	59511805	59511805	+	Missense_Mutation	SNP	A	A	C			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr8:59511805A>C	ENST00000038176.3	-	19	1783	c.1571T>G	c.(1570-1572)gTt>gGt	p.V524G	NSMAF_ENST00000519858.1_5'Flank|NSMAF_ENST00000427130.2_Missense_Mutation_p.V555G	NM_003580.3	NP_003571.2	Q92636	FAN_HUMAN	neutral sphingomyelinase (N-SMase) activation associated factor	524	BEACH.	NA		NA	ceramide metabolic process	cytoplasm|soluble fraction	protein binding|receptor signaling protein activity			autonomic_ganglia(1)|central_nervous_system(1)|endometrium(7)|kidney(3)|large_intestine(7)|lung(11)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|urinary_tract(1)	38		all_lung(136;0.174)|Lung NSC(129;0.2)				ATGGGCCCCAACTGCATCACT	0.338		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						162	154	157	NA		NA	NA	8		NA		NA									NA				59511805		2203	4300	6503	SO:0001583	missense			ENSG00000035681	HGNC:8017	NM_003580	Approved	uc011lee.2	NA	Q8IW26	ENST00000038176.3	37	CCDS6173.1	.	.	.	.	.	.	.	.	.	.	A	12.39	1.922480	0.33908	.	.	ENSG00000035681	ENST00000038176;ENST00000427130	T;T	0.66638	-0.22;-0.22	6.17	6.17	0.99709	BEACH domain (4);	0.449133	0.24447	N	0.038454	D	0.84629	0.5514	M	0.94021	3.485	0.37183	D	0.9036	P;P	0.49862	0.929;0.758	P;P	0.57204	0.815;0.713	D	0.90197	0.4254	9	.	.	.	.	16.8222	0.85835	1.0:0.0:0.0:0.0	.	555;524	Q92636-2;Q92636	.;FAN_HUMAN	G	524;555	ENSP00000038176:V524G;ENSP00000411012:V555G	.	V	-	2	0	NSMAF	59674359	0.977000	0.34250	0.040000	0.18447	0.002000	0.02628	7.412000	0.80091	2.371000	0.80710	0.533000	0.62120	GTT	NSMAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000378384.1	39.138355	KEEP	NA	-	71.431875	0.111111	24	192	---	---	---	---	1	0.985223	4	55	0	287	27	231	0	287	2	0	0	0	0	0	0	27	231	0	287	2	TP
EIF3A	8661	broad.mit.edu	37	10	120797843	120797843	+	Missense_Mutation	SNP	T	T	A			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr10:120797843T>A	ENST00000369144.3	-	20	3762	c.3635A>T	c.(3634-3636)gAt>gTt	p.D1212V	EIF3A_ENST00000541549.1_Missense_Mutation_p.D1178V|EIF3A_ENST00000478852.1_Intron	NM_003750.2	NP_003741.1	Q14152	EIF3A_HUMAN	eukaryotic translation initiation factor 3, subunit A	1212	Asp-rich.	NA		NA	formation of translation initiation complex	cytosol|eukaryotic translation initiation factor 3 complex	protein binding|structural molecule activity|translation initiation factor activity			endometrium(8)|kidney(4)|large_intestine(14)|lung(22)|prostate(1)|skin(4)|urinary_tract(3)	56		Lung NSC(174;0.094)|all_lung(145;0.123)		all cancers(201;0.0236)		atcttgattatctctgtccct	0.488		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						276	230	246	NA		NA	NA	10		NA		NA									NA				120797843		2203	4300	6503	SO:0001583	missense			ENSG00000107581	HGNC:3271	NM_003750	Approved	uc001ldu.3	NA	B1AMV5|O00653|Q15778	ENST00000369144.3	37	CCDS7608.1	.	.	.	.	.	.	.	.	.	.	T	9.383	1.073450	0.20147	.	.	ENSG00000107581	ENST00000369144;ENST00000541549	T;T	0.29397	1.57;1.61	4.11	4.11	0.48088	.	0.180767	0.25628	U	0.029365	T	0.37517	0.1006	L	0.39898	1.24	0.58432	D	0.99999	D;B	0.61080	0.989;0.241	P;B	0.59487	0.858;0.151	T	0.04216	-1.0968	10	0.31617	T	0.26	-13.6853	9.8198	0.40876	0.0:0.0:0.0:1.0	.	1178;1212	F5H335;Q14152	.;EIF3A_HUMAN	V	1212;1178	ENSP00000358140:D1212V;ENSP00000438178:D1178V	ENSP00000358140:D1212V	D	-	2	0	EIF3A	120787833	0.998000	0.40836	0.851000	0.33527	0.804000	0.45430	4.447000	0.60020	2.090000	0.63153	0.459000	0.35465	GAT	EIF3A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000050634.1	-23.46369	KEEP	NA	-	18.47492	0.042781	8	179	---	---	---	---	1	0.9999959	30	597	0	151	9	185	0	151	2	0	0	0	0	0	0	9	185	0	151	2	TP
C1R	715	broad.mit.edu	37	12	7188364	7188364	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr12:7188364C>A	ENST00000542285.1	-	11	1583	c.1434G>T	c.(1432-1434)atG>atT	p.M478I				P00736	C1R_HUMAN	complement component 1, r subcomponent	530	Peptidase S1.	NA		NA	complement activation, classical pathway|innate immune response|proteolysis	extracellular region	calcium ion binding|serine-type endopeptidase activity			endometrium(4)|kidney(1)|large_intestine(4)|lung(6)|pancreas(1)	16					Abciximab(DB00054)|Adalimumab(DB00051)|Alefacept(DB00092)|Alemtuzumab(DB00087)|Basiliximab(DB00074)|Bevacizumab(DB00112)|Cetuximab(DB00002)|Daclizumab(DB00111)|Efalizumab(DB00095)|Etanercept(DB00005)|Gemtuzumab ozogamicin(DB00056)|Ibritumomab(DB00078)|Immune globulin(DB00028)|Muromonab(DB00075)|Natalizumab(DB00108)|Palivizumab(DB00110)|Rituximab(DB00073)|Tositumomab(DB00081)|Trastuzumab(DB00072)	TTCCTAGCTTCATGAGCTCTT	0.567		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						123	131	128	NA		NA	NA	12		NA		NA									NA				7188364		2198	4298	6496	SO:0001583	missense			ENSG00000159403	HGNC:1246	NM_001733	Approved	uc010sfy.2	NA	A6NJQ8|Q68D77|Q8J012	ENST00000542285.1	37		.	.	.	.	.	.	.	.	.	.	C	2.966	-0.213475	0.06140	.	.	ENSG00000159403	ENST00000290575;ENST00000542285	D	0.88431	-2.38	5.44	-0.148	0.13424	Peptidase cysteine/serine, trypsin-like (1);Peptidase S1/S6, chymotrypsin/Hap (3);	1.278400	0.05190	N	0.502986	T	0.81805	0.4900	.	.	.	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.63866	-0.6540	9	0.35671	T	0.21	.	6.8157	0.23829	0.0:0.2486:0.4235:0.3279	.	530	P00736	C1R_HUMAN	I	493;478	ENSP00000438615:M478I	ENSP00000290575:M493I	M	-	3	0	C1R	7058619	0.000000	0.05858	0.002000	0.10522	0.027000	0.11550	-0.324000	0.07986	-0.360000	0.08138	-0.274000	0.10170	ATG	C1R-201	KNOWN	basic	protein_coding	NA	protein_coding		5.530639	KEEP	NA	-	41.525661	0.08	16	184	---	---	---	---	1	1	31	410	0	145	18	209	0	145	2	0	0	0	0	0	0	18	209	0	145	2	TP
CLEC16A	23274	broad.mit.edu	37	16	11217709	11217709	+	Silent	SNP	C	C	T			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr16:11217709C>T	ENST00000409790.1	+	21	2609	c.2379C>T	c.(2377-2379)ttC>ttT	p.F793F	CLEC16A_ENST00000409552.3_Silent_p.F775F|CLEC16A_ENST00000465491.1_3'UTR|CLEC16A_ENST00000381822.2_5'Flank	NM_015226.2	NP_056041.1	Q2KHT3	CL16A_HUMAN	C-type lectin domain family 16, member A	793		NA		NA				p.0?(1)		breast(1)|central_nervous_system(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(10)|lung(12)|ovary(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	37						AGGCCACCTTCATCTTCTCAG	0.602		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				1	Whole gene deletion(1)	haematopoietic_and_lymphoid_tissue(1)	NA	NA	NA	NA	NA						62	68	66	NA		NA	NA	16		NA		NA									NA				11217709		2118	4237	6355	SO:0001819	synonymous_variant			ENSG00000038532	HGNC:29013	NM_015226	Approved	uc002dao.3	NA	O15058|Q6ZTB2	ENST00000409790.1	37	CCDS45409.1	.	.	.	.	.	.	.	.	.	.	C	10.70	1.424865	0.25639	.	.	ENSG00000038532	ENST00000428742	.	.	.	5.55	2.31	0.28768	.	.	.	.	.	T	0.53965	0.1829	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.41752	-0.9491	4	.	.	.	-23.1287	6.2745	0.20973	0.0:0.3426:0.0:0.6574	.	.	.	.	L	37	.	.	S	+	2	0	CLEC16A	11125210	0.922000	0.31269	0.849000	0.33467	0.997000	0.91878	0.606000	0.24194	0.211000	0.20683	0.655000	0.94253	TCA	CLEC16A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000328540.2	6.700522	KEEP	NA	+	22.883657	0.092784	9	88	---	---	---	---	1	0.9876737	12	48	0	57	12	91	0	57	2	0	0	0	0	0	0	12	91	0	57	2	TP
CDK12	51755	broad.mit.edu	37	17	37618323	37618323	+	5'UTR	SNP	G	G	A			THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr17:37618323G>A	ENST00000447079.4	+	0	32				CDK12_ENST00000430627.2_5'UTR	NM_015083.1|NM_016507.2	NP_055898.1|NP_057591.2	Q9NYV4	CDK12_HUMAN	cyclin-dependent kinase 12	NA		NA		NA	mRNA processing|phosphorylation of RNA polymerase II C-terminal domain|protein autophosphorylation|regulation of MAP kinase activity|RNA splicing	nuclear cyclin-dependent protein kinase holoenzyme complex|nuclear speck|nucleolus	ATP binding|cyclin-dependent protein kinase activity|protein binding|RNA polymerase II carboxy-terminal domain kinase activity			NS(4)|breast(3)|endometrium(5)|kidney(4)|large_intestine(11)|lung(23)|ovary(11)|prostate(4)|skin(2)|urinary_tract(3)	70						AGGGGAAAGGGAATGCCCAAT	0.587		NA	"""Mis, N, F"""		serous ovarian	NA		NA		TCGA Ovarian(9;0.13)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA	Rec	yes	NA	17	17q12	51755	cyclin-dependent kinase 12		E	0			NA	NA	NA	NA	NA						64	68	67	NA		NA	NA	17		NA		NA									NA				37618323		2203	4300	6503	SO:0001623	5_prime_UTR_variant			ENSG00000167258	HGNC:24224	NM_016507	Approved	uc010cvv.3	NA	A7E2B2|B4DYX4|B9EIQ6|O94978	ENST00000447079.4	37	CCDS11337.1																																																																																			CDK12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256941.4	127.062667	KEEP	NA	+	129.768184	0.338983	40	78	---	---	---	---	1	0.7845748	5	3	0	81	43	90	0	81	2	0	0	0	0	0	0	43	90	0	81	2	TP
PLTP	5360	broad.mit.edu	37	20	44539816	44539816	+	Missense_Mutation	SNP	C	C	A	rs139898818	byFrequency	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-H2-A421-Tumor-SM-3M3US	THCA-TCGA-H2-A421-Normal-SM-3M518	g.chr20:44539816C>A	ENST00000542937.1	-	2	769	c.235G>T	c.(235-237)Ggc>Tgc	p.G79C	PLTP_ENST00000372420.1_5'Flank|PLTP_ENST00000420868.2_Missense_Mutation_p.G59C|PLTP_ENST00000372431.3_Missense_Mutation_p.G59C|PLTP_ENST00000354050.4_Missense_Mutation_p.G59C|PLTP_ENST00000477313.1_Missense_Mutation_p.G59C			P55058	PLTP_HUMAN	phospholipid transfer protein	59		NA		NA	cellular lipid metabolic process|lipid transport	extracellular region	lipid binding			endometrium(2)|kidney(2)|large_intestine(8)|lung(8)|ovary(1)	21		Myeloproliferative disorder(115;0.0122)				TAGAAGTGGCCTTCTTTGCCC	0.617		NA				NA		NA			NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						88	90	89	NA		NA	NA	20		NA		NA									NA				44539816		2203	4300	6503	SO:0001583	missense			ENSG00000100979	HGNC:9093	NM_006227	Approved	uc002xqn.2	NA	A8K006|E1P5N8|Q8WTT1|Q9BR07|Q9BSH8	ENST00000542937.1	37		.	.	.	.	.	.	.	.	.	.	C	23.0	4.356569	0.82243	.	.	ENSG00000100979	ENST00000372431;ENST00000354050;ENST00000477313;ENST00000542937;ENST00000420868	T;T;T;T;T	0.08720	3.06;3.06;3.06;3.06;3.06	5.2	4.24	0.50183	Lipid-binding serum glycoprotein, N-terminal (2);Bactericidal permeability-increasing protein, alpha/beta domain (1);	0.049033	0.85682	D	0.000000	T	0.30510	0.0767	M	0.79123	2.44	0.58432	D	0.999999	D;D;D;D;D;D	0.89917	0.994;0.994;1.0;1.0;1.0;1.0	P;P;D;D;D;D	0.85130	0.804;0.804;0.996;0.993;0.996;0.997	T	0.14117	-1.0484	10	0.87932	D	0	-9.823	15.8394	0.78835	0.0:0.8639:0.1361:0.0	.	59;59;59;59;59;79	E7EV16;B4DRB4;Q53H91;P55058-2;P55058;B3KUE5	.;.;.;.;PLTP_HUMAN;.	C	59;59;59;79;59	ENSP00000361508:G59C;ENSP00000335290:G59C;ENSP00000417138:G59C;ENSP00000440296:G79C;ENSP00000411671:G59C	ENSP00000335290:G59C	G	-	1	0	PLTP	43973223	1.000000	0.71417	0.588000	0.28705	0.984000	0.73092	6.763000	0.74955	1.397000	0.46682	0.563000	0.77884	GGC	PLTP-201	KNOWN	basic	protein_coding	NA	protein_coding		6.984766	KEEP	NA	-	36.913739	0.086705	15	158	---	---	---	---	1	0.9999854	3	189	0	139	19	188	0	139	2	0	0	0	0	0	0	19	188	0	139	2	TP
